Old Web
English
Sign In
Acemap
>
Paper
>
Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern.
Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern.
2020
Karolina Akinosoglou
Charalambos Gogos
Keywords:
Virology
Tocilizumab
severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Interleukin-6 Receptor Antagonist
2019 20 coronavirus outbreak
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
2
Citations
NaN
KQI
[]